Product Information
MESALAMINE ER 0.375 GRAM CAP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.4979 per EA under NDC 62332072435. Its NADAC has been published 136 times since Nov 22, 2023.
Strength
.375 g/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332072435
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA216967On Market Since
11/3/2022
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE ER 0.375 GRAM CAP has been published 136 times since Nov 22, 2023, and over the history we have for it it has declined 39.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4979 per EA |
|---|---|
| All-time high | $0.9198 (Feb 14, 2024) |
| All-time low | $0.4196 (Feb 18, 2026) |
| 52-week high | $0.4979 |
| 52-week low | $0.4196 |
| Median price | $0.4914 |
| Average price | $0.5425 |
| Largest weekly change | -38.7% (Jul 17, 2024) |
| Weeks tracked | 136 |
| Tracking since | Nov 22, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the MESALAMINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MESALAMINE ER 0.375 GRAM CAP?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE ER 0.375 GRAM CAP, manufactured by Alembic Pharmaceuticals Inc., is $0.4979 per EA (NDC 62332072435), effective Jun 24, 2026.
How has the price of MESALAMINE ER 0.375 GRAM CAP changed over time?
Over the history we have for it, the NADAC for MESALAMINE ER 0.375 GRAM CAP has declined 39.2%. It has been tracked across 136 weekly CMS publications since Nov 22, 2023.
What are the highest and lowest recorded NADAC prices for MESALAMINE ER 0.375 GRAM CAP?
Since Nov 22, 2023, the NADAC for MESALAMINE ER 0.375 GRAM CAP has ranged from a low of $0.4196 (Feb 18, 2026) to a high of $0.9198 (Feb 14, 2024), with a median of $0.4914 per EA.
Are there cheaper alternatives to MESALAMINE ER 0.375 GRAM CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MESALAMINE ER 0.375 GRAM CAP, so no direct lower-cost alternative is listed.
Who manufactures MESALAMINE ER 0.375 GRAM CAP?
MESALAMINE ER 0.375 GRAM CAP (NDC 62332072435) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification